In this work, the AI-guided protein design approach was employed to design an artificial protein CEABP1 de novo for specific recognition of the tumor biomarker of CRC, carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5, abbreviated as CEA hereafter) [49,50]. Here, CEACAM5 is linked to neoplasm.